HPC Specialty Pharmacy Announces They Have Been Selected By Genentech As A Provider Of HEMLIBRAŽ

Tuesday, January 16, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

MOBILE, Ala., Jan. 16, 2018 /PRNewswire/ -- HPC Specialty Pharmacy is proud to announce they have been selected as an authorized

provider of HEMLIBRAŽ, Genentech's new treatment product for patients diagnosed with hemophilia A with inhibitors. Chief Executive Officer Ron Cieutat stated, "With the addition of HEMLIBRAŽ to our therapy plan, HPC continues
to show our commitment to empowering our patients with the ability to achieve the highest quality of life."

HEMLIBRAŽ is a FDA approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with factor VIII inhibitors. For a full product description of HEMLIBRAŽ, including Important Safety Information, visit www.hemlibra.com. To refer your patient to HPC Specialty Pharmacy for HEMLIBRAŽ therapy, please contact HPC at 1-800-757-9192 or follow this link to submit a completed patient referral form.  

Not Just a Pharmacy! HPC's two founding leaders, Todd Vereen (a hemophilia patient) and Ron Cieutat (a Registered Nurse) used their knowledge and understanding of chronic illnesses and their associated care requirements, to hand craft a truly focused, patient-centered team approach to services and care. HPC's expert Care Teams provide coordinated services, support, and education that help patients and health care providers manage all aspects of the patient's therapy. HPC monitors their medical conditions, ensures proper medication use and adherence, and assists with the management of the financial and insurance aspects of the drug therapy. With accreditations from ACHC, CHAP, JCAHO, and URAC, HPC assures that they meet the highest standards of quality and excellence in the Specialty Pharmacy industry. Visit www.hpcspecialtypharmacy.com to learn more about HPC's patient-centric services, Care Teams, and industry leading experience that sets them apart from all other specialty pharmacies in the nation.

Cision View original content:http://www.prnewswire.com/news-releases/hpc-specialty-pharmacy-announces-they-have-been-selected-by-genentech-as-a-provider-of-hemlibra-300582177.html

SOURCE HPC Specialty Pharmacy



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store